Market Overview

Benzinga's Weekend M&A Chatter

Share:
Benzinga's Weekend M&A Chatter
Related AMGN
Portfolio Manager Says Now Is A Great Time To Buy Biotech
A Big Biotech ETF Is About To Get Cheaper
Archford Capital Strategies, LLC Buys Vanguard S&P 5……, British American Tobacco PLC, ... (GuruFocus)

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday August 22 through Sunday August 25, 2013:

UPDATE: Amgen Acquires Onyx Pharmaceuticals for $125/Share in Cash

The Deal:
Amgen (NASDAQ: AMGN) and Onyx Pharmaceuticals (NASDAQ: ONXX) announced Sunday that their Boards of Directors have unanimously approved Amgen's purchase of the outstanding shares of Onyx for $125 per share in cash or $10.4 billion.

The deal is expected to close at the beginning of Q4 2013.

Onyx Pharmaceuticals closed at $116.94 Friday, a loss of $0.63.

Baidu Acquires 59% Interest in Renren's Nuomi for $160M in Cash

The Deal:
Baidu (NASDAQ: BIDU) and Renren (NYSE: RENN) announced Friday that Baidu Holdings will acquire approximately 59% of the equity interest in Nuomi Holdings, a wholly-owned subsidiary of Renren, for $160 million in cash. The deal is expected to close in Q4 2013.

Baidu closed at $138.64.86 Friday, a loss of $0.90, while Renren closed at $3.56, a gain of more than 4.5%.

BATS, Direct Edge Reportedly in Merger Talks

The Rumor:
The BATS and Direct Edge exchanges are reportedly in merger talks, according to the Wall Street Journal. A combination of the rival exchanges would be larger than the Nasdaq OMX Group (NASDAQ: NDAQ), currently the second largest US exchange behind the NYSE Euronext (NYSE: NYX).

Nasdaq OMX Group closed at $30.83 Friday, a gain of more than 1%, while NYSE Euronext closed at $42.66, losing $0.03.

Posted-In: News Rumors M&A Global

 

Related Articles (AMGN + ONXX)

View Comments and Join the Discussion!

Partner Center